<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38163173</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>29</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2405-8440</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>15</Day></PubDate></JournalIssue><Title>Heliyon</Title><ISOAbbreviation>Heliyon</ISOAbbreviation></Journal><ArticleTitle>Proteomic profiling identifies biomarkers of COVID-19 severity.</ArticleTitle><Pagination><StartPage>e23320</StartPage><MedlinePgn>e23320</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e23320</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.heliyon.2023.e23320</ELocationID><Abstract><AbstractText>SARS-CoV-2 infection remains a major public health concern, particularly for the aged and those individuals with co-morbidities at risk for developing severe COVID-19. Understanding the pathogenesis and biomarkers associated with responses to SARS-CoV-2 infection remain critical components in developing effective therapeutic approaches, especially in cases of severe and long-COVID-19. In this study blood plasma protein expression was compared in subjects with mild, moderate, and severe COVID-19 disease. Evaluation of an inflammatory protein panel confirms upregulation of proteins including TNF&#x3b2;, IL-6, IL-8, IL-12, already associated with severe cytokine storm and progression to severe COVID-19. Importantly, we identify several proteins not yet associated with COVID-19 disease, including mesothelin (MSLN), that are expressed at significantly higher levels in severe COVID-19 subjects. In addition, we find a subset of markers associated with T-cell and dendritic cell responses to viral infection that are significantly higher in mild cases and decrease in expression as severity of COVID-19 increases, suggesting that an immediate and effective activation of T-cells is critical in modulating disease progression. Together, our findings identify new targets for further investigation as therapeutic approaches for the treatment of SARS-CoV-2 infection and prevention of complications of severe COVID-19.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Harriott</LastName><ForeName>Noa C</ForeName><Initials>NC</Initials><AffiliationInfo><Affiliation>Hastings Center for Pulmonary Research, Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Southern California, Los Angeles CA 90033, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Stem Cell Biology and Regenerative Medicine, University of Southern California, Los Angeles CA 90033, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anatomy and Cell Biology, Carver College of Medicine, University of Iowa, Iowa City IA 52240, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ryan</LastName><ForeName>Amy L</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Hastings Center for Pulmonary Research, Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, University of Southern California, Los Angeles CA 90033, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Stem Cell Biology and Regenerative Medicine, University of Southern California, Los Angeles CA 90033, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anatomy and Cell Biology, Carver College of Medicine, University of Iowa, Iowa City IA 52240, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 DK054759</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Heliyon</MedlineTA><NlmUniqueID>101672560</NlmUniqueID><ISSNLinking>2405-8440</ISSNLinking></MedlineJournalInfo><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>2</Day><Hour>11</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>2</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>1</Day><Hour>4</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38163173</ArticleId><ArticleId IdType="pmc">PMC10755324</ArticleId><ArticleId IdType="doi">10.1016/j.heliyon.2023.e23320</ArticleId><ArticleId IdType="pii">S2405-8440(23)10528-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727&#x2013;733. doi: 10.1056/NEJMoa2001017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X., Liu L., Shan H., Lei C.L., Hui D.S.C., et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020;382:1708&#x2013;1720. doi: 10.1056/NEJMoa2002032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J., Deng Y.K., Wang H., Wang Z.C., Liao B., Ma J., He C., Pan L., Liu Y., Alobid I., et al. Self-reported taste and smell disorders in patients with COVID-19: distinct features in China. Curr Med Sci. 2021;41:14&#x2013;23. doi: 10.1007/s11596-021-2312-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11596-021-2312-7</ArticleId><ArticleId IdType="pmc">PMC7881907</ArticleId><ArticleId IdType="pubmed">33582900</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z., Xiong Y., et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan, China. JAMA. 2020;323:1061&#x2013;1069. doi: 10.1001/jama.2020.1585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Rass V., Beer R., Schiefecker A.J., Lindner A., Kofler M., Ianosi B.A., Mahlknecht P., Heim B., Peball M., Carbone F., et al. Neurological outcomes 1 year after COVID-19 diagnosis: a prospective longitudinal cohort study. Eur. J. Neurol. 2022;29:1685&#x2013;1696. doi: 10.1111/ene.15307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15307</ArticleId><ArticleId IdType="pmc">PMC9111823</ArticleId><ArticleId IdType="pubmed">35239247</ArticleId></ArticleIdList></Reference><Reference><Citation>de Miranda D.A.P., Gomes S.V.C., Filgueiras P.S., Corsini C.A., Almeida N.B.F., Silva R.A., Medeiros M., Vilela R.V.R., Fernandes G.R., Grenfell R.F.Q. Long COVID-19 syndrome: a 14-months longitudinal study during the two first epidemic peaks in Southeast Brazil. Trans. R. Soc. Trop. Med. Hyg. 2022 doi: 10.1093/trstmh/trac030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/trstmh/trac030</ArticleId><ArticleId IdType="pubmed">35514142</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai A.D., Lavelle M., Boursiquot B.C., Wan E.Y. Long-term complications of COVID-19. Am J Physiol Cell Physiol. 2022;322:C1&#x2013;C11. doi: 10.1152/ajpcell.00375.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00375.2021</ArticleId><ArticleId IdType="pmc">PMC8721906</ArticleId><ArticleId IdType="pubmed">34817268</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA. 2020;323:1239&#x2013;1242. doi: 10.1001/jama.2020.2648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Schafer E., Scheer C., Salje K., Fritz A., Kohlmann T., Hubner N.O., Napp M., Fiedler-Lacombe L., Stahl D., Rauch B., et al. Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection. Sci. Rep. 2022;12:7249. doi: 10.1038/s41598-022-11103-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-11103-0</ArticleId><ArticleId IdType="pmc">PMC9065670</ArticleId><ArticleId IdType="pubmed">35508524</ArticleId></ArticleIdList></Reference><Reference><Citation>Buttenschon H.N., Lynggaard V., Sandbol S.G., Glassou E.N., Haagerup A. Comparison of the clinical presentation across two waves of COVID-19: a retrospective cohort study. BMC Infect. Dis. 2022;22:423. doi: 10.1186/s12879-022-07413-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-022-07413-3</ArticleId><ArticleId IdType="pmc">PMC9063242</ArticleId><ArticleId IdType="pubmed">35505306</ArticleId></ArticleIdList></Reference><Reference><Citation>Letko M., Marzi A., Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020;5:562&#x2013;569. doi: 10.1038/s41564-020-0688-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-020-0688-y</ArticleId><ArticleId IdType="pmc">PMC7095430</ArticleId><ArticleId IdType="pubmed">32094589</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kruger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271&#x2013;280 e278. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh M., Bansal V., Feschotte C. A single-cell RNA expression map of human coronavirus entry factors. Cell Rep. 2020;32 doi: 10.1016/j.celrep.2020.108175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108175</ArticleId><ArticleId IdType="pmc">PMC7470764</ArticleId><ArticleId IdType="pubmed">32946807</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrehart T., Suryadinata R., McCafferty C., Jacobson J., Ignjatovic V., Robinson P., Crawford N.W., Monagle P., Subbarao K., Satzke C., Wurzel D. Age-related differences in SARS-CoV-2 binding factors: an explanation for reduced susceptibility to severe COVID-19 among children? Paediatr. Respir. Rev. 2022 doi: 10.1016/j.prrv.2022.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prrv.2022.01.008</ArticleId><ArticleId IdType="pmc">PMC8823960</ArticleId><ArticleId IdType="pubmed">35227628</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrario C.M., Jessup J., Chappell M.C., Averill D.B., Brosnihan K.B., Tallant E.A., Diz D.I., Gallagher P.E. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005;111:2605&#x2013;2610. doi: 10.1161/CIRCULATIONAHA.104.510461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.104.510461</ArticleId><ArticleId IdType="pubmed">15897343</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z., Flammer A.J., Steiger P., Haberecker M., Andermatt R., Zinkernagel A.S., Mehra M.R., Schuepbach R.A., Ruschitzka F., Moch H. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417&#x2013;1418. doi: 10.1016/S0140-6736(20)30937-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P., Curtis N. Why does the severity of COVID-19 differ with age?: understanding the mechanisms underlying the age gradient in outcome following SARS-CoV-2 infection. Pediatr. Infect. Dis. J. 2022;41:e36&#x2013;e45. doi: 10.1097/INF.0000000000003413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003413</ArticleId><ArticleId IdType="pmc">PMC8740029</ArticleId><ArticleId IdType="pubmed">34966142</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma D., Liu S., Hu L., He Q., Shi W., Yan D., Cao Y., Zhang G., Wang Z., Wu J., Jiang C. Single-cell RNA sequencing identify SDCBP in ACE2-positive bronchial epithelial cells negatively correlates with COVID-19 severity. J. Cell Mol. Med. 2021;25:7001&#x2013;7012. doi: 10.1111/jcmm.16714.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.16714</ArticleId><ArticleId IdType="pmc">PMC8278084</ArticleId><ArticleId IdType="pubmed">34137173</ArticleId></ArticleIdList></Reference><Reference><Citation>Loske J., Rohmel J., Lukassen S., Stricker S., Magalhaes V.G., Liebig J., Chua R.L., Thurmann L., Messingschlager M., Seegebarth A., et al. Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children. Nat. Biotechnol. 2022;40:319&#x2013;324. doi: 10.1038/s41587-021-01037-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-021-01037-9</ArticleId><ArticleId IdType="pubmed">34408314</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce C.A., Sy S., Galen B., Goldstein D.Y., Orner E., Keller M.J., Herold K.C., Herold B.C. Natural mucosal barriers and COVID-19 in children. JCI Insight. 2021;6 doi: 10.1172/jci.insight.148694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.148694</ArticleId><ArticleId IdType="pmc">PMC8262299</ArticleId><ArticleId IdType="pubmed">33822777</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultze J.L., Aschenbrenner A.C. COVID-19 and the human innate immune system. Cell. 2021;184:1671&#x2013;1692. doi: 10.1016/j.cell.2021.02.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.02.029</ArticleId><ArticleId IdType="pmc">PMC7885626</ArticleId><ArticleId IdType="pubmed">33743212</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrara M.R., Bonfante F., Costenaro P., Cantarutti A., Carmona F., Ruffoni E., Di Chiara C., Zanchetta M., Barzon L., Dona D., et al. Asymptomatic and mild SARS-CoV-2 infections elicit lower immune activation and higher specific neutralizing antibodies in children than in adults. Front. Immunol. 2021;12 doi: 10.3389/fimmu.2021.741796.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.741796</ArticleId><ArticleId IdType="pmc">PMC8515185</ArticleId><ArticleId IdType="pubmed">34659235</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen C.A., Li A.P.Y., Hachim A., Hui D.S.C., Kwan M.Y.W., Tsang O.T.Y., Chiu S.S., Chan W.H., Yau Y.S., Kavian N., et al. SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection. Nat. Commun. 2021;12:4678. doi: 10.1038/s41467-021-24938-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24938-4</ArticleId><ArticleId IdType="pmc">PMC8322064</ArticleId><ArticleId IdType="pubmed">34326343</ArticleId></ArticleIdList></Reference><Reference><Citation>Blank C.U., Haining W.N., Held W., Hogan P.G., Kallies A., Lugli E., Lynn R.C., Philip M., Rao A., Restifo N.P., et al. Defining 'T cell exhaustion. Nat. Rev. Immunol. 2019;19:665&#x2013;674. doi: 10.1038/s41577-019-0221-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-019-0221-9</ArticleId><ArticleId IdType="pmc">PMC7286441</ArticleId><ArticleId IdType="pubmed">31570879</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer S., Cunniffe N., Donnelly R. COVID-19 hospitalization rates rise exponentially with age, inversely proportional to thymic T-cell production. J R Soc Interface. 2021;18 doi: 10.1098/rsif.2020.0982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsif.2020.0982</ArticleId><ArticleId IdType="pmc">PMC8086881</ArticleId><ArticleId IdType="pubmed">33726544</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang P.H., Ding Y.B., Xu Z., Pu R., Li P., Yan J., Liu J.L., Meng F.P., Huang L., Shi L., et al. Increased circulating level of interleukin-6 and CD8(+) T cell exhaustion are associated with progression of COVID-19. Infect Dis Poverty. 2020;9:161. doi: 10.1186/s40249-020-00780-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-020-00780-6</ArticleId><ArticleId IdType="pmc">PMC7686818</ArticleId><ArticleId IdType="pubmed">33239109</ArticleId></ArticleIdList></Reference><Reference><Citation>Westmeier J., Paniskaki K., Karakose Z., Werner T., Sutter K., Dolff S., Overbeck M., Limmer A., Liu J., Zheng X., et al. Impaired cytotoxic CD8(+) T cell response in elderly COVID-19 patients. mBio. 2020;11 doi: 10.1128/mBio.02243-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02243-20</ArticleId><ArticleId IdType="pmc">PMC7502863</ArticleId><ArticleId IdType="pubmed">32948688</ArticleId></ArticleIdList></Reference><Reference><Citation>Files J.K., Boppana S., Perez M.D., Sarkar S., Lowman K.E., Qin K., Sterrett S., Carlin E., Bansal A., Sabbaj S., et al. Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection. J. Clin. Invest. 2021;131 doi: 10.1172/JCI140491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI140491</ArticleId><ArticleId IdType="pmc">PMC7773371</ArticleId><ArticleId IdType="pubmed">33119547</ArticleId></ArticleIdList></Reference><Reference><Citation>von Mering C., Jensen L.J., Snel B., Hooper S.D., Krupp M., Foglierini M., Jouffre N., Huynen M.A., Bork P. STRING: known and predicted protein-protein associations, integrated and transferred across organisms. Nucleic Acids Res. 2005;33(Database issue) doi: 10.1093/nar/gki005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gki005</ArticleId><ArticleId IdType="pmc">PMC539959</ArticleId><ArticleId IdType="pubmed">15608232</ArticleId></ArticleIdList></Reference><Reference><Citation>Renelus B.D., Khoury N.C., Chandrasekaran K., Bekele E., Briggs W.M., Ivanov A., Mohanty S.R., Jamorabo D.S. Racial disparities in COVID-19 hospitalization and in-hospital mortality at the height of the New York city pandemic. J Racial Ethn Health Disparities. 2021;8:1161&#x2013;1167. doi: 10.1007/s40615-020-00872-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40615-020-00872-x</ArticleId><ArticleId IdType="pmc">PMC7500250</ArticleId><ArticleId IdType="pubmed">32946070</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiumento G., Yousey-Hindes K., Edmundson A., Hadler J.L. Persistence of racial/ethnic and socioeconomic status disparities among non-institutionalized patients hospitalized with COVID-19 in Connecticut, July to December 2020. Influenza Other Respir Viruses. 2022;16:532&#x2013;541. doi: 10.1111/irv.12945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12945</ArticleId><ArticleId IdType="pmc">PMC8983889</ArticleId><ArticleId IdType="pubmed">34874099</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikami T., Miyashita H., Yamada T., Harrington M., Steinberg D., Dunn A., Siau E. Risk factors for mortality in patients with COVID-19 in New York city. J. Gen. Intern. Med. 2021;36:17&#x2013;26. doi: 10.1007/s11606-020-05983-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-020-05983-z</ArticleId><ArticleId IdType="pmc">PMC7325642</ArticleId><ArticleId IdType="pubmed">32607928</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Agnillo F., Walters K.A., Xiao Y., Sheng Z.M., Scherler K., Park J., Gygli S., Rosas L.A., Sadtler K., Kalish H., et al. Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19. Sci. Transl. Med. 2021;13 doi: 10.1126/scitranslmed.abj7790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abj7790</ArticleId><ArticleId IdType="pmc">PMC11000440</ArticleId><ArticleId IdType="pubmed">34648357</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi U., Nchioua R., Prata L., Zhu Y., Gerdes E.O.W., Giorgadze N., Pirtskhalava T., Parker E., Xue A., Espindola-Netto J.M., et al. SARS-CoV-2 causes senescence in human cells and exacerbates the senescence-associated secretory phenotype through TLR-3. Aging (Albany NY) 2021;13:21838&#x2013;21854. doi: 10.18632/aging.203560.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.203560</ArticleId><ArticleId IdType="pmc">PMC8507266</ArticleId><ArticleId IdType="pubmed">34531331</ArticleId></ArticleIdList></Reference><Reference><Citation>Suleyman G., Fadel R., Brar I., Kassab R., Khansa R., Sturla N., Alsaadi A., Latack K., Miller J., Tibbetts R., et al. Risk factors associated with hospitalization and death in COVID-19 breakthrough infections. Open Forum Infect. Dis. 2022;9:ofac116. doi: 10.1093/ofid/ofac116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac116</ArticleId><ArticleId IdType="pmc">PMC8903475</ArticleId><ArticleId IdType="pubmed">35437511</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell C.D., Valanciute A., Gachanja N.N., Stephen J., Penrice-Randal R., Armstrong S.D., Clohisey S., Wang B., Al Qsous W., Wallace W.A., et al. Tissue proteomic analysis identifies mechanisms and stages of immunopathology in fatal COVID-19. Am. J. Respir. Cell Mol. Biol. 2022;66:196&#x2013;205. doi: 10.1165/rcmb.2021-0358OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2021-0358OC</ArticleId><ArticleId IdType="pmc">PMC8845132</ArticleId><ArticleId IdType="pubmed">34710339</ArticleId></ArticleIdList></Reference><Reference><Citation>Zoodsma M., de Nooijer A.H., Grondman I., Gupta M.K., Bonifacius A., Koeken V., Kooistra E., Kilic G., Bulut O., Godecke N., et al. Targeted proteomics identifies circulating biomarkers associated with active COVID-19 and post-COVID-19. Front. Immunol. 2022;13 doi: 10.3389/fimmu.2022.1027122.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1027122</ArticleId><ArticleId IdType="pmc">PMC9670186</ArticleId><ArticleId IdType="pubmed">36405747</ArticleId></ArticleIdList></Reference><Reference><Citation>Razaghi A., Szakos A., Alouda M., Bozoky B., Bjornstedt M., Szekely L. Proteomic analysis of pleural effusions from COVID-19 deceased patients: enhanced inflammatory markers. Diagnostics. 2022;12 doi: 10.3390/diagnostics12112789.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics12112789</ArticleId><ArticleId IdType="pmc">PMC9689825</ArticleId><ArticleId IdType="pubmed">36428847</ArticleId></ArticleIdList></Reference><Reference><Citation>Feyaerts D., Hedou J., Gillard J., Chen H., Tsai E.S., Peterson L.S., Ando K., Manohar M., Do E., Dhondalay G.K.R., et al. Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19. Cell Rep Med. 2022;3 doi: 10.1016/j.xcrm.2022.100680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100680</ArticleId><ArticleId IdType="pmc">PMC9238057</ArticleId><ArticleId IdType="pubmed">35839768</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Nesf M.A.Y., Abdesselem H.B., Bensmail I., Ibrahim S., Saeed W.A.H., Mohammed S.S.I., Razok A., Alhussain H., Aly R.M.A., Al Maslamani M., et al. Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications. Nat. Commun. 2022;13:946. doi: 10.1038/s41467-022-28639-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-28639-4</ArticleId><ArticleId IdType="pmc">PMC8854716</ArticleId><ArticleId IdType="pubmed">35177642</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossegesse M., Bourquain D., Neumann M., Schaade L., Schulze J., Mache C., Wolff T., Nitsche A., Doellinger J. Deep time course proteomics of SARS-CoV- and SARS-CoV-2-infected human lung epithelial cells (Calu-3) reveals strong induction of interferon-stimulated gene expression by SARS-CoV-2 in contrast to SARS-CoV. J. Proteome Res. 2022;21:459&#x2013;469. doi: 10.1021/acs.jproteome.1c00783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.1c00783</ArticleId><ArticleId IdType="pubmed">34982558</ArticleId></ArticleIdList></Reference><Reference><Citation>McArdle A., Washington K.E., Chazarin Orgel B., Binek A., Manalo D.M., Rivas A., Ayres M., Pandey R., Phebus C., Raedschelders K., et al. Discovery proteomics for COVID-19: where we are now. J. Proteome Res. 2021;20:4627&#x2013;4639. doi: 10.1021/acs.jproteome.1c00475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.1c00475</ArticleId><ArticleId IdType="pmc">PMC8482317</ArticleId><ArticleId IdType="pubmed">34550702</ArticleId></ArticleIdList></Reference><Reference><Citation>Villar M., Urra J.M., Rodriguez-Del-Rio F.J., Artigas-Jeronimo S., Jimenez-Collados N., Ferreras-Colino E., Contreras M., de Mera I.G.F., Estrada-Pena A., Gortazar C., de la Fuente J. Characterization by quantitative serum proteomics of immune-related prognostic biomarkers for COVID-19 symptomatology. Front. Immunol. 2021;12 doi: 10.3389/fimmu.2021.730710.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.730710</ArticleId><ArticleId IdType="pmc">PMC8457011</ArticleId><ArticleId IdType="pubmed">34566994</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J., Schank M., Wang L., Dang X., Cao D., Khanal S., Nguyen L.N.T., Zhang Y., Wu X.Y., Adkins J.L., et al. Plasma biomarkers for systemic inflammation in COVID-19 survivors. Proteomics Clin Appl. 2022;16 doi: 10.1002/prca.202200031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prca.202200031</ArticleId><ArticleId IdType="pmc">PMC9539278</ArticleId><ArticleId IdType="pubmed">35929818</ArticleId></ArticleIdList></Reference><Reference><Citation>Suhre K., Sarwath H., Engelke R., Sohail M.U., Cho S.J., Whalen W., Alvarez-Mulett S., Krumsiek J., Choi A.M.K., Schmidt F. Identification of robust protein associations with COVID-19 disease based on five clinical studies. Front. Immunol. 2021;12 doi: 10.3389/fimmu.2021.781100.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.781100</ArticleId><ArticleId IdType="pmc">PMC8821526</ArticleId><ArticleId IdType="pubmed">35145507</ArticleId></ArticleIdList></Reference><Reference><Citation>Gisby J., Clarke C.L., Medjeral-Thomas N., Malik T.H., Papadaki A., Mortimer P.M., Buang N.B., Lewis S., Pereira M., Toulza F., et al. Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death. Elife. 2021;10 doi: 10.7554/eLife.64827.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.64827</ArticleId><ArticleId IdType="pmc">PMC8064756</ArticleId><ArticleId IdType="pubmed">33704068</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel H., Ashton N.J., Dobson R.J.B., Andersson L.M., Yilmaz A., Blennow K., Gisslen M., Zetterberg H. Proteomic blood profiling in mild, severe and critical COVID-19 patients. Sci. Rep. 2021;11:6357. doi: 10.1038/s41598-021-85877-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-85877-0</ArticleId><ArticleId IdType="pmc">PMC7973581</ArticleId><ArticleId IdType="pubmed">33737684</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J.W., Zhang C., Fan X., Meng F.P., Xu Z., Xia P., Cao W.J., Yang T., Dai X.P., Wang S.Y., et al. Immunological and inflammatory profiles in mild and severe cases of COVID-19. Nat. Commun. 2020;11:3410. doi: 10.1038/s41467-020-17240-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17240-2</ArticleId><ArticleId IdType="pmc">PMC7343781</ArticleId><ArticleId IdType="pubmed">32641700</ArticleId></ArticleIdList></Reference><Reference><Citation>Maldonado F., Morales D., Diaz-Papapietro C., Valdes C., Fernandez C., Valls N., Lazo M., Espinoza C., Gonzalez R., Gutierrez R., et al. Relationship between endothelial and angiogenesis biomarkers envisage mortality in a prospective cohort of COVID-19 patients requiring respiratory support. Front. Med. 2022;9 doi: 10.3389/fmed.2022.826218.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.826218</ArticleId><ArticleId IdType="pmc">PMC8966493</ArticleId><ArticleId IdType="pubmed">35372407</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D., Li L., Chen Y., Ma J., Yang Y., Aodeng S., Cui Q., Wen K., Xiao M., Xie J., et al. Syndecan-1, an indicator of endothelial glycocalyx degradation, predicts outcome of patients admitted to an ICU with COVID-19. Mol Med. 2021;27:151. doi: 10.1186/s10020-021-00412-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-021-00412-1</ArticleId><ArticleId IdType="pmc">PMC8640509</ArticleId><ArticleId IdType="pubmed">34861818</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng H.L., Chen D., Yan J., Yang Q., Han Q.Q., Li S.S., Cheng L. Proteomic characteristics of bronchoalveolar lavage fluid in critical COVID-19 patients. FEBS J. 2021;288:5190&#x2013;5200. doi: 10.1111/febs.15609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.15609</ArticleId><ArticleId IdType="pubmed">33098359</ArticleId></ArticleIdList></Reference><Reference><Citation>Teng Y.H., Aquino R.S., Park P.W. Molecular functions of syndecan-1 in disease. Matrix Biol. 2012;31:3&#x2013;16. doi: 10.1016/j.matbio.2011.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.matbio.2011.10.001</ArticleId><ArticleId IdType="pmc">PMC3568394</ArticleId><ArticleId IdType="pubmed">22033227</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogawa F., Oi Y., Nakajima K., Matsumura R., Nakagawa T., Miyagawa T., Sakai K., Saji R., Taniguchi H., Takahashi K., et al. Temporal change in Syndecan-1 as a therapeutic target and a biomarker for the severity classification of COVID-19. Thromb. J. 2021;19:55. doi: 10.1186/s12959-021-00308-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12959-021-00308-4</ArticleId><ArticleId IdType="pmc">PMC8366156</ArticleId><ArticleId IdType="pubmed">34399775</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupont A., Rauch A., Staessens S., Moussa M., Rosa M., Corseaux D., Jeanpierre E., Goutay J., Caplan M., Varlet P., et al. Vascular endothelial damage in the pathogenesis of organ injury in severe COVID-19. Arterioscler. Thromb. Vasc. Biol. 2021;41:1760&#x2013;1773. doi: 10.1161/ATVBAHA.120.315595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.120.315595</ArticleId><ArticleId IdType="pubmed">33626910</ArticleId></ArticleIdList></Reference><Reference><Citation>Karampoor S., Zahednasab H., Farahmand M., Mirzaei R., Zamani F., Tabibzadeh A., Bouzari B., Ajdarkosh H., Nikkhah M., Hashemi M.R., et al. A possible pathogenic role of Syndecan-1 in the pathogenesis of coronavirus disease 2019 (COVID-19) Int. Immunopharm. 2021;97 doi: 10.1016/j.intimp.2021.107684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107684</ArticleId><ArticleId IdType="pmc">PMC8052477</ArticleId><ArticleId IdType="pubmed">33932696</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson P.I., Stensballe J., Rasmussen L.S., Ostrowski S.R. A high admission syndecan-1 level, a marker of endothelial glycocalyx degradation, is associated with inflammation, protein C depletion, fibrinolysis, and increased mortality in trauma patients. Ann. Surg. 2011;254:194&#x2013;200. doi: 10.1097/SLA.0b013e318226113d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0b013e318226113d</ArticleId><ArticleId IdType="pubmed">21772125</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahl K., Gronski P.A., Kiyan Y., Seeliger B., Bertram A., Pape T., Welte T., Hoeper M.M., Haller H., David S. Injury to the endothelial glycocalyx in critically ill patients with COVID-19. Am. J. Respir. Crit. Care Med. 2020;202:1178&#x2013;1181. doi: 10.1164/rccm.202007-2676LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202007-2676LE</ArticleId><ArticleId IdType="pmc">PMC7560808</ArticleId><ArticleId IdType="pubmed">32833500</ArticleId></ArticleIdList></Reference><Reference><Citation>Hudak A., Letoha A., Szilak L., Letoha T. Contribution of syndecans to the cellular entry of SARS-CoV-2. Int. J. Mol. Sci. 2021;22 doi: 10.3390/ijms22105336.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22105336</ArticleId><ArticleId IdType="pmc">PMC8159090</ArticleId><ArticleId IdType="pubmed">34069441</ArticleId></ArticleIdList></Reference><Reference><Citation>Bermejo-Jambrina M., Eder J., Kaptein T.M., van Hamme J.L., Helgers L.C., Vlaming K.E., Brouwer P.J.M., van Nuenen A.C., Spaargaren M., de Bree G.J., et al. Infection and transmission of SARS-CoV-2 depend on heparan sulfate proteoglycans. EMBO J. 2021;40 doi: 10.15252/embj.2020106765.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020106765</ArticleId><ArticleId IdType="pmc">PMC8521309</ArticleId><ArticleId IdType="pubmed">34510494</ArticleId></ArticleIdList></Reference><Reference><Citation>Foell D., Kane D., Bresnihan B., Vogl T., Nacken W., Sorg C., Fitzgerald O., Roth J. Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology. 2003;42:1383&#x2013;1389. doi: 10.1093/rheumatology/keg385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keg385</ArticleId><ArticleId IdType="pubmed">12832707</ArticleId></ArticleIdList></Reference><Reference><Citation>Ligthart S., Sedaghat S., Ikram M.A., Hofman A., Franco O.H., Dehghan A. EN-RAGE: a novel inflammatory marker for incident coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 2014;34:2695&#x2013;2699. doi: 10.1161/ATVBAHA.114.304306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.114.304306</ArticleId><ArticleId IdType="pubmed">25341801</ArticleId></ArticleIdList></Reference><Reference><Citation>Foell D., Seeliger S., Vogl T., Koch H.G., Maschek H., Harms E., Sorg C., Roth J. Expression of S100A12 (EN-RAGE) in cystic fibrosis. Thorax. 2003;58:613&#x2013;617. doi: 10.1136/thorax.58.7.613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thorax.58.7.613</ArticleId><ArticleId IdType="pmc">PMC1746749</ArticleId><ArticleId IdType="pubmed">12832680</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu R., Liu Y., Yan R., Liu X., Duan L. Assessment of EN-RAGE, sRAGE and EN-RAGE/sRAGE as potential biomarkers in patients with autoimmune hepatitis. J. Transl. Med. 2020;18:384. doi: 10.1186/s12967-020-02556-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02556-w</ArticleId><ArticleId IdType="pmc">PMC7547460</ArticleId><ArticleId IdType="pubmed">33036620</ArticleId></ArticleIdList></Reference><Reference><Citation>Foell D., Ichida F., Vogl T., Yu X., Chen R., Miyawaki T., Sorg C., Roth J. S100A12 (EN-RAGE) in monitoring Kawasaki disease. Lancet. 2003;361:1270&#x2013;1272. doi: 10.1016/S0140-6736(03)12986-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(03)12986-8</ArticleId><ArticleId IdType="pubmed">12699958</ArticleId></ArticleIdList></Reference><Reference><Citation>Thwaites R.S., Sanchez Sevilla Uruchurtu A., Siggins M.K., Liew F., Russell C.D., Moore S.C., Fairfield C., Carter E., Abrams S., Short C.E., et al. Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19. Sci Immunol. 2021;6 doi: 10.1126/sciimmunol.abg9873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abg9873</ArticleId><ArticleId IdType="pmc">PMC8128298</ArticleId><ArticleId IdType="pubmed">33692097</ArticleId></ArticleIdList></Reference><Reference><Citation>Tserel L., Jogi P., Naaber P., Maslovskaja J., Haling A., Salumets A., Zusinaite E., Soeorg H., Lattekivi F., Ingerainen D., et al. Long-Term elevated inflammatory protein levels in asymptomatic SARS-CoV-2 infected individuals. Front. Immunol. 2021;12 doi: 10.3389/fimmu.2021.709759.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.709759</ArticleId><ArticleId IdType="pmc">PMC8484961</ArticleId><ArticleId IdType="pubmed">34603283</ArticleId></ArticleIdList></Reference><Reference><Citation>Acevedo N., Escamilla-Gil J.M., Espinoza H., Regino R., Ramirez J., Florez de Arco L., Dennis R., Torres-Duque C.A., Caraballo L. Chronic obstructive pulmonary disease patients have increased levels of plasma inflammatory mediators reported upregulated in severe COVID-19. Front. Immunol. 2021;12 doi: 10.3389/fimmu.2021.678661.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.678661</ArticleId><ArticleId IdType="pmc">PMC8320593</ArticleId><ArticleId IdType="pubmed">34335580</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerayeli F.V., Milne S., Cheung C., Li X., Yang C.W.T., Tam A., Choi L.H., Bae A., Sin D.D. COPD and the risk of poor outcomes in COVID-19: a systematic review and meta-analysis. EClinicalMedicine. 2021;33 doi: 10.1016/j.eclinm.2021.100789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100789</ArticleId><ArticleId IdType="pmc">PMC7971471</ArticleId><ArticleId IdType="pubmed">33758801</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiappalupi S., Salvadori L., Vukasinovic A., Donato R., Sorci G., Riuzzi F. Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: hypotheses and perspectives. Life Sci. 2021;272 doi: 10.1016/j.lfs.2021.119251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2021.119251</ArticleId><ArticleId IdType="pmc">PMC7900755</ArticleId><ArticleId IdType="pubmed">33636175</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiappalupi S., Salvadori L., Donato R., Riuzzi F., Sorci G. Hyperactivated RAGE in comorbidities as a risk factor for severe COVID-19-the role of RAGE-RAS crosstalk. Biomolecules. 2021;11 doi: 10.3390/biom11060876.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11060876</ArticleId><ArticleId IdType="pmc">PMC8231494</ArticleId><ArticleId IdType="pubmed">34204735</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo X.H., Zhu Y., Mao J., Du R.C. T cell immunobiology and cytokine storm of COVID-19. Scand. J. Immunol. 2021;93 doi: 10.1111/sji.12989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sji.12989</ArticleId><ArticleId IdType="pmc">PMC7645942</ArticleId><ArticleId IdType="pubmed">33113222</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S.T., Park M.D., Del Valle D.M., Buckup M., Tabachnikova A., Simons N.W., Mouskas K., Lee B., Geanon D., D'Souza D., et al. Shift of lung macrophage composition is associated with COVID-19 disease severity and recovery. bioRxiv. 2022 doi: 10.1101/2022.01.11.475918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.11.475918</ArticleId><ArticleId IdType="pmc">PMC10117220</ArticleId><ArticleId IdType="pubmed">36103512</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B., Huang S., Yin L. The cytokine storm and COVID-19. J. Med. Virol. 2021;93:250&#x2013;256. doi: 10.1002/jmv.26232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26232</ArticleId><ArticleId IdType="pmc">PMC7361342</ArticleId><ArticleId IdType="pubmed">32592501</ArticleId></ArticleIdList></Reference><Reference><Citation>Song P., Li W., Xie J., Hou Y., You C. Cytokine storm induced by SARS-CoV-2. Clin. Chim. Acta. 2020;509:280&#x2013;287. doi: 10.1016/j.cca.2020.06.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2020.06.017</ArticleId><ArticleId IdType="pmc">PMC7283076</ArticleId><ArticleId IdType="pubmed">32531256</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Jiang M., Chen X., Montaner L.J. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts. J. Leukoc. Biol. 2020;108:17&#x2013;41. doi: 10.1002/JLB.3COVR0520-272R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JLB.3COVR0520-272R</ArticleId><ArticleId IdType="pmc">PMC7323250</ArticleId><ArticleId IdType="pubmed">32534467</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins C.A., Petukhova L., Harel S., Ho Y.Y., Drill E., Shapiro L., Wajid M., Christiano A.M. FGF5 is a crucial regulator of hair length in humans. Proc Natl Acad Sci U S A. 2014;111:10648&#x2013;10653. doi: 10.1073/pnas.1402862111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1402862111</ArticleId><ArticleId IdType="pmc">PMC4115575</ArticleId><ArticleId IdType="pubmed">24989505</ArticleId></ArticleIdList></Reference><Reference><Citation>Ushach I., Zlotnik A. Biological role of granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) on cells of the myeloid lineage. J. Leukoc. Biol. 2016;100:481&#x2013;489. doi: 10.1189/jlb.3RU0316-144R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.3RU0316-144R</ArticleId><ArticleId IdType="pmc">PMC4982611</ArticleId><ArticleId IdType="pubmed">27354413</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimatsu Y., Kimuro S., Pauty J., Takagaki K., Nomiyama S., Inagawa A., Maeda K., Podyma-Inoue K.A., Kajiya K., Matsunaga Y.T., Watabe T. TGF-beta and TNF-alpha cooperatively induce mesenchymal transition of lymphatic endothelial cells via activation of Activin signals. PLoS One. 2020;15 doi: 10.1371/journal.pone.0232356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0232356</ArticleId><ArticleId IdType="pmc">PMC7194440</ArticleId><ArticleId IdType="pubmed">32357159</ArticleId></ArticleIdList></Reference><Reference><Citation>Iulita M.F., Cuello A.C. The NGF metabolic pathway in the CNS and its dysregulation in down syndrome and alzheimer's disease. Curr. Alzheimer Res. 2016;13:53&#x2013;67. doi: 10.2174/1567205012666150921100030.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567205012666150921100030</ArticleId><ArticleId IdType="pubmed">26391047</ArticleId></ArticleIdList></Reference><Reference><Citation>Bragado P., Fernandez-Nogueira P., Carbo N., Gascon P. Unraveling the role of fibroblasts, FGF5 and FGFR2 in HER2-targeted therapies resistance and tumor progression. Oncotarget. 2020;11:4541&#x2013;4543. doi: 10.18632/oncotarget.27829.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.27829</ArticleId><ArticleId IdType="pmc">PMC7733626</ArticleId><ArticleId IdType="pubmed">33346249</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannarile M.A., Weisser M., Jacob W., Jegg A.M., Ries C.H., Ruttinger D. Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy. J Immunother Cancer. 2017;5:53. doi: 10.1186/s40425-017-0257-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40425-017-0257-y</ArticleId><ArticleId IdType="pmc">PMC5514481</ArticleId><ArticleId IdType="pubmed">28716061</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng J., Lu S.S., Xiao T., Huang W., Yi H., Zhu W., Fan S., Feng X.P., Li J.Y., Yu Z.Z., et al. ANXA1 binds and stabilizes EphA2 to promote nasopharyngeal carcinoma growth and metastasis. Cancer Res. 2020;80:4386&#x2013;4398. doi: 10.1158/0008-5472.CAN-20-0560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-20-0560</ArticleId><ArticleId IdType="pubmed">32737118</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Liang R., Song C., Xiang Y., Liu Y. Prognostic significance of epidermal growth factor receptor expression in glioma patients. OncoTargets Ther. 2018;11:731&#x2013;742. doi: 10.2147/OTT.S155160.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/OTT.S155160</ArticleId><ArticleId IdType="pmc">PMC5808691</ArticleId><ArticleId IdType="pubmed">29445288</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B., Cai S., Zhao Y., He Q., Yu X., Cheng L., Zhang Y., Hu X., Ke M., Chen S., Zou M. Nerve growth factor modulates the tumor cells migration in ovarian cancer through the WNT/beta-catenin pathway. Oncotarget. 2016;7:81026&#x2013;81048. doi: 10.18632/oncotarget.13186.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.13186</ArticleId><ArticleId IdType="pmc">PMC5348374</ArticleId><ArticleId IdType="pubmed">27835587</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosmuller H., Matter M., Fend F., Tzankov A. The pulmonary pathology of COVID-19. Virchows Arch. 2021;478:137&#x2013;150. doi: 10.1007/s00428-021-03053-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00428-021-03053-1</ArticleId><ArticleId IdType="pmc">PMC7892326</ArticleId><ArticleId IdType="pubmed">33604758</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostergaard L. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol Rep. 2021;9 doi: 10.14814/phy2.14726.</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.14726</ArticleId><ArticleId IdType="pmc">PMC7849453</ArticleId><ArticleId IdType="pubmed">33523608</ArticleId></ArticleIdList></Reference><Reference><Citation>Laforge M., Elbim C., Frere C., Hemadi M., Massaad C., Nuss P., Benoliel J.J., Becker C. Tissue damage from neutrophil-induced oxidative stress in COVID-19. Nat. Rev. Immunol. 2020;20:515&#x2013;516. doi: 10.1038/s41577-020-0407-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0407-1</ArticleId><ArticleId IdType="pmc">PMC7388427</ArticleId><ArticleId IdType="pubmed">32728221</ArticleId></ArticleIdList></Reference><Reference><Citation>Esquivel D., Mishra R., Soni P., Seetharaman R., Mahmood A., Srivastava A. Stem cells therapy as a possible therapeutic option in treating COVID-19 patients. Stem Cell Rev Rep. 2021;17:144&#x2013;152. doi: 10.1007/s12015-020-10017-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-020-10017-6</ArticleId><ArticleId IdType="pmc">PMC7395577</ArticleId><ArticleId IdType="pubmed">32740890</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajarshi K., Chatterjee A., Ray S. Combating COVID-19 with mesenchymal stem cell therapy. Biotechnol Rep (Amst) 2020;26 doi: 10.1016/j.btre.2020.e00467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.btre.2020.e00467</ArticleId><ArticleId IdType="pmc">PMC7224671</ArticleId><ArticleId IdType="pubmed">32420049</ArticleId></ArticleIdList></Reference><Reference><Citation>Pastan I., Hassan R. Discovery of mesothelin and exploiting it as a target for immunotherapy. Cancer Res. 2014;74:2907&#x2013;2912. doi: 10.1158/0008-5472.CAN-14-0337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-14-0337</ArticleId><ArticleId IdType="pmc">PMC4062095</ArticleId><ArticleId IdType="pubmed">24824231</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan R., Bera T., Pastan I. Mesothelin: a new target for immunotherapy. Clin. Cancer Res. 2004;10:3937&#x2013;3942. doi: 10.1158/1078-0432.CCR-03-0801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-03-0801</ArticleId><ArticleId IdType="pubmed">15217923</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassan R., Ho M. Mesothelin targeted cancer immunotherapy. Eur. J. Cancer. 2008;44:46&#x2013;53. doi: 10.1016/j.ejca.2007.08.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejca.2007.08.028</ArticleId><ArticleId IdType="pmc">PMC2265108</ArticleId><ArticleId IdType="pubmed">17945478</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneko O., Gong L., Zhang J., Hansen J.K., Hassan R., Lee B., Ho M. A binding domain on mesothelin for CA125/MUC16. J. Biol. Chem. 2009;284:3739&#x2013;3749. doi: 10.1074/jbc.M806776200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M806776200</ArticleId><ArticleId IdType="pmc">PMC2635045</ArticleId><ArticleId IdType="pubmed">19075018</ArticleId></ArticleIdList></Reference><Reference><Citation>Muniyan S., Haridas D., Chugh S., Rachagani S., Lakshmanan I., Gupta S., Seshacharyulu P., Smith L.M., Ponnusamy M.P., Batra S.K. MUC16 contributes to the metastasis of pancreatic ductal adenocarcinoma through focal adhesion mediated signaling mechanism. Genes Cancer. 2016;7:110&#x2013;124. doi: 10.18632/genesandcancer.104.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/genesandcancer.104</ArticleId><ArticleId IdType="pmc">PMC4918949</ArticleId><ArticleId IdType="pubmed">27382435</ArticleId></ArticleIdList></Reference><Reference><Citation>Bera T.K., Pastan I. Mesothelin is not required for normal mouse development or reproduction. Mol. Cell Biol. 2000;20:2902&#x2013;2906. doi: 10.1128/MCB.20.8.2902-2906.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.20.8.2902-2906.2000</ArticleId><ArticleId IdType="pmc">PMC85523</ArticleId><ArticleId IdType="pubmed">10733593</ArticleId></ArticleIdList></Reference><Reference><Citation>Leibbrandt A., Penninger J.M. RANK/RANKL: regulators of immune responses and bone physiology. Ann. N. Y. Acad. Sci. 2008;1143:123&#x2013;150. doi: 10.1196/annals.1443.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1443.016</ArticleId><ArticleId IdType="pubmed">19076348</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang P., Hou Y.Q., Wu J.J., Wang Y.D., Ye X.Y., Zang F., Yu R.B., Yang S. Genetic mutations in TNFSF11 were associated with the chronicity of hepatitis C among Chinese han population. Front. Med. 2021;8 doi: 10.3389/fmed.2021.743406.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.743406</ArticleId><ArticleId IdType="pmc">PMC8517249</ArticleId><ArticleId IdType="pubmed">34660648</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonardi A.J., Argyropoulos C.P., Hamdy A., Proenca R.B. Understanding the effects of age and T-cell differentiation on COVID-19 severity: implicating a fas/FasL-mediated feed-forward controller of T-cell differentiation. Front. Immunol. 2022;13 doi: 10.3389/fimmu.2022.853606.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.853606</ArticleId><ArticleId IdType="pmc">PMC8927653</ArticleId><ArticleId IdType="pubmed">35309371</ArticleId></ArticleIdList></Reference><Reference><Citation>de Almeida Chuffa L.G., Freire P.P., Dos Santos Souza J., de Mello M.C., de Oliveira Neto M., Carvalho R.F. Aging whole blood transcriptome reveals candidate genes for SARS-CoV-2-related vascular and immune alterations. J. Mol. Med. (Berl.) 2022;100:285&#x2013;301. doi: 10.1007/s00109-021-02161-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-021-02161-4</ArticleId><ArticleId IdType="pmc">PMC8571664</ArticleId><ArticleId IdType="pubmed">34741638</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagata S. Fas ligand-induced apoptosis. Annu. Rev. Genet. 1999;33:29&#x2013;55. doi: 10.1146/annurev.genet.33.1.29.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.genet.33.1.29</ArticleId><ArticleId IdType="pubmed">10690403</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams J.W., Ferreira C.M., Blaine K.M., Rayon C., Velazquez F., Tong J., Peter M.E., Sperling A.I. Non-apoptotic Fas (CD95) signaling on T cells regulates the resolution of Th2-mediated inflammation. Front. Immunol. 2018;9:2521. doi: 10.3389/fimmu.2018.02521.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02521</ArticleId><ArticleId IdType="pmc">PMC6221963</ArticleId><ArticleId IdType="pubmed">30443253</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma S.K., Almeida F.A., Kierstein S., Hortobagyi L., Lin T., Larkin A., Peterson J., Yagita H., Zangrilli J.G., Haczku A. Systemic FasL neutralization increases eosinophilic inflammation in a mouse model of asthma. Allergy. 2012;67:328&#x2013;335. doi: 10.1111/j.1398-9995.2011.02763.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1398-9995.2011.02763.x</ArticleId><ArticleId IdType="pmc">PMC3278510</ArticleId><ArticleId IdType="pubmed">22175699</ArticleId></ArticleIdList></Reference><Reference><Citation>Leonardi A.J., Proenca R.B. Akt-fas to quell aberrant T cell differentiation and apoptosis in covid-19. Front. Immunol. 2020;11 doi: 10.3389/fimmu.2020.600405.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.600405</ArticleId><ArticleId IdType="pmc">PMC7779612</ArticleId><ArticleId IdType="pubmed">33408715</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramljak D., Vukoja M., Curlin M., Vukojevic K., Barbaric M., Glamoclija U., Purisevic B., Peric O., Soljic V. Early response of CD8+ T cells in COVID-19 patients. J Pers Med. 2021;11 doi: 10.3390/jpm11121291.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm11121291</ArticleId><ArticleId IdType="pmc">PMC8704882</ArticleId><ArticleId IdType="pubmed">34945761</ArticleId></ArticleIdList></Reference><Reference><Citation>Andre S., Picard M., Cezar R., Roux-Dalvai F., Alleaume-Butaux A., Soundaramourty C., Cruz A.S., Mendes-Frias A., Gotti C., Leclercq M., et al. T cell apoptosis characterizes severe Covid-19 disease. Cell Death Differ. 2022 doi: 10.1038/s41418-022-00936-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-022-00936-x</ArticleId><ArticleId IdType="pmc">PMC8782710</ArticleId><ArticleId IdType="pubmed">35066575</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen E.R., Hallberg P., Baranova E.V., Eriksson N., Karawajczyk M., Johansson C., Cavalli M., Maroteau C., Veluchamy A., Islander G., et al. Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment. Pharmacogenomics J. 2020;20:770&#x2013;783. doi: 10.1038/s41397-020-0165-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41397-020-0165-2</ArticleId><ArticleId IdType="pmc">PMC7674154</ArticleId><ArticleId IdType="pubmed">32080354</ArticleId></ArticleIdList></Reference><Reference><Citation>Pall A.H., Rasmussen E.R., Wadelius M. Pharmacogenetics of angiotensin-converting enzyme inhibitor-induced angioedema. Pharmacogenomics. 2021;22:319&#x2013;321. doi: 10.2217/pgs-2021-0036.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/pgs-2021-0036</ArticleId><ArticleId IdType="pubmed">33849279</ArticleId></ArticleIdList></Reference><Reference><Citation>Montinaro V., Cicardi M. ACE inhibitor-mediated angioedema. Int. Immunopharm. 2020;78 doi: 10.1016/j.intimp.2019.106081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2019.106081</ArticleId><ArticleId IdType="pubmed">31835086</ArticleId></ArticleIdList></Reference><Reference><Citation>Garvin M.R., Alvarez C., Miller J.I., Prates E.T., Walker A.M., Amos B.K., Mast A.E., Justice A., Aronow B., Jacobson D. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm. Elife. 2020;9 doi: 10.7554/eLife.59177.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.59177</ArticleId><ArticleId IdType="pmc">PMC7410499</ArticleId><ArticleId IdType="pubmed">32633718</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Veerdonk F.L., Netea M.G., van Deuren M., van der Meer J.W., de Mast Q., Bruggemann R.J., van der Hoeven H. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome. Elife. 2020;9 doi: 10.7554/eLife.57555.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.57555</ArticleId><ArticleId IdType="pmc">PMC7213974</ArticleId><ArticleId IdType="pubmed">32338605</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche J.A., Roche R. A hypothesized role for dysregulated bradykinin signaling in COVID-19 respiratory complications. Faseb. J. 2020;34:7265&#x2013;7269. doi: 10.1096/fj.202000967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202000967</ArticleId><ArticleId IdType="pmc">PMC7267506</ArticleId><ArticleId IdType="pubmed">32359101</ArticleId></ArticleIdList></Reference><Reference><Citation>Khodadoost M., Niknam Z., Farahani M., Razzaghi M., Norouzinia M. Investigating the human protein-host protein interactome of SARS-CoV-2 infection in the small intestine. Gastroenterol Hepatol Bed Bench. 2020;13:374&#x2013;387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7682973</ArticleId><ArticleId IdType="pubmed">33244381</ArticleId></ArticleIdList></Reference><Reference><Citation>Saih A., Baba H., Bouqdayr M., Ghazal H., Hamdi S., Kettani A., Wakrim L. In silico analysis of high-risk missense variants in human ACE2 gene and susceptibility to SARS-CoV-2 infection. BioMed Res. Int. 2021;2021 doi: 10.1155/2021/6685840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/6685840</ArticleId><ArticleId IdType="pmc">PMC8040925</ArticleId><ArticleId IdType="pubmed">33884270</ArticleId></ArticleIdList></Reference><Reference><Citation>Foo S.S., Cambou M.C., Mok T., Fajardo V.M., Jung K.L., Fuller T., Chen W., Kerin T., Mei J., Bhattacharya D., et al. The systemic inflammatory landscape of COVID-19 in pregnancy: extensive serum proteomic profiling of mother-infant dyads with in utero SARS-CoV-2. Cell Rep Med. 2021;2 doi: 10.1016/j.xcrm.2021.100453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2021.100453</ArticleId><ArticleId IdType="pmc">PMC8549189</ArticleId><ArticleId IdType="pubmed">34723226</ArticleId></ArticleIdList></Reference><Reference><Citation>Idoyaga J., Cheong C., Suda K., Suda N., Kim J.Y., Lee H., Park C.G., Steinman R.M. Cutting edge: langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo. J. Immunol. 2008;180:3647&#x2013;3650. doi: 10.4049/jimmunol.180.6.3647.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.180.6.3647</ArticleId><ArticleId IdType="pubmed">18322168</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Y., Cao J., Zhang X., Gao H., Wang Y., Wang J., He J., Jiang X., Zhang J., Shen G., et al. Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2. Cell Res. 2022;32:24&#x2013;37. doi: 10.1038/s41422-021-00595-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41422-021-00595-6</ArticleId><ArticleId IdType="pmc">PMC8617373</ArticleId><ArticleId IdType="pubmed">34837059</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou R., To K.K., Wong Y.C., Liu L., Zhou B., Li X., Huang H., Mo Y., Luk T.Y., Lau T.T., et al. Acute SARS-CoV-2 infection impairs dendritic cell and T cell responses. Immunity. 2020;53:864&#x2013;877 e865. doi: 10.1016/j.immuni.2020.07.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.07.026</ArticleId><ArticleId IdType="pmc">PMC7402670</ArticleId><ArticleId IdType="pubmed">32791036</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Gomez A., Vitalle J., Gasca-Capote C., Gutierrez-Valencia A., Trujillo-Rodriguez M., Serna-Gallego A., Munoz-Muela E., Jimenez-Leon M.L.R., Rafii-El-Idrissi Benhnia M., Rivas-Jeremias I., et al. Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection. Cell. Mol. Immunol. 2021;18:2128&#x2013;2139. doi: 10.1038/s41423-021-00728-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-021-00728-2</ArticleId><ArticleId IdType="pmc">PMC8294321</ArticleId><ArticleId IdType="pubmed">34290398</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Y., Liu Y., Cao L., Wang D., Guo M., Jiang A., Guo D., Hu W., Yang J., Tang Z., et al. Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. Emerg. Microb. Infect. 2020;9:761&#x2013;770. doi: 10.1080/22221751.2020.1747363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1747363</ArticleId><ArticleId IdType="pmc">PMC7170362</ArticleId><ArticleId IdType="pubmed">32228226</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>